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A B S T R A C T
Background
In 2010, theWorld Health Organization recommended that all patients with suspected malaria are tested for malaria before treatment.
In rural African settings light microscopy is often unavailable. Diagnosis has relied on detecting fever, and most people were given
antimalarial drugs presumptively. Rapid diagnostic tests (RDTs) provide a point-of-care test that may improvemanagement, particularly
of people for whom the RDT excludes the diagnosis of malaria.
Objectives
To evaluate whether introducing RDTs into algorithms for diagnosing and treating people with fever improves health outcomes, reduces
antimalarial prescribing, and is safe, compared to algorithms using clinical diagnosis.
Search methods
We searched the Cochrane Infectious Disease Group Specialized Register; CENTRAL (The Cochrane Library); MEDLINE; EMBASE;
CINAHL; LILACS; and the metaRegister of Controlled Trials for eligible trials up to 10 January 2014. We contacted researchers in
the field and reviewed the reference lists of all included trials to identify any additional trials.
Selection criteria
Individual or cluster randomized trials (RCTs) comparing RDT-supported algorithms and algorithms using clinical diagnosis alone for
diagnosing and treating people with fever living in malaria-endemic settings.
Data collection and analysis
Two authors independently applied the inclusion criteria and extracted data. We combined data from individually and cluster RCTs
using the generic inverse variance method. We presented all outcomes as risk ratios (RR) with 95% confidence intervals (CIs), and
assessed the quality of evidence using the GRADE approach.
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Main results
We included seven trials, enrolling 17,505 people with fever or reported history of fever in this review; two individually randomized
trials and five cluster randomized trials. All trials were conducted in rural African settings.
In most trials the health workers diagnosing and treating malaria were nurses or clinical officers with less than one week of training in
RDT supported diagnosis. Health worker prescribing adherence to RDT results was highly variable: the number of participants with
a negative RDT result who received antimalarials ranged from 0% to 81%.
Overall, RDT supported diagnosis had little or no effect on the number of participants remaining unwell at four to seven days after
treatment (6990 participants, five trials, low quality evidence); but using RDTs reduced prescribing of antimalarials by up to three-
quarters (17,287 participants, seven trials, moderate quality evidence). As would be expected, the reduction in antimalarial prescriptions
was highest where health workers adherence to the RDT result was high, and where the true prevalence of malaria was lower.
Using RDTs to support diagnosis did not have a consistent effect on the prescription of antibiotics, with some trials showing higher
antibiotic prescribing and some showing lower prescribing in the RDT group (13,573 participants, five trials, very low quality evidence).
One trial reported malaria microscopy on all enrolled patients in an area of moderate endemicity, so we could compare the number
of patients in the RDT and clinical diagnosis groups that actually had microscopy confirmed malaria infection but did not receive
antimalarials. No difference was detected between the two diagnostic strategies (1280 participants, one trial, low quality evidence).
Authors’ conclusions
Algorithms incorporating RDTs can substantially reduce antimalarial prescribing if health workers adhere to the test results. Introducing
RDTs has not been shown to improve health outcomes for patients, but adherence to the test result does not seem to result in worse
clinical outcomes than presumptive treatment.
Concentrating on improving the care of RDT negative patients could improve health outcomes in febrile children.
P L A I N L A N G U A G E S U M M A R Y
Rapid diagnostic tests versus clinical diagnosis for managing fever in settings where malaria is common
Cochrane Collaboration researchers conducted a review of the effects of introducing rapid diagnostic tests (RDTs) for diagnosing
malaria in areas where diagnosis has traditionally been based on clinical symptoms alone. After searching for relevant trials, they included
seven randomized controlled trials, which enrolled 17,505 people with fever.
What are RDTs and how might they improve patient care
RDTs are simple to use diagnostic kits which can detect the parasites that cause malaria from one drop of the patient’s blood. They do
not require laboratory facilities or extensive training, and can provide a simple positive or negative result within 20 minutes, making
them suitable for use in rural areas of Africa where most malaria cases occur.
Improving malaria diagnosis by introducing RDTs is unlikely to improve the health outcomes of people with true malaria as they would
probably have received antimalarials even if the health worker was relying on clinical symptoms alone. However, for patients with fever
not due to malaria, RDTs could improve health outcomes by prompting the health worker to look for and treat the true cause of their
fever earlier.
What the research says
In these trials, diagnosis using RDTs had little or no effect on the number of people remaining unwell four to seven days after treatment
(low quality evidence).
However, using RDTs reduced the prescription of antimalarials by up to three-quarters (moderate quality evidence), and this reduction
was highest where health workers only prescribed antimalarials following a positive test, and where malaria was less common.
Using RDTs to support diagnosis did not have a consistent effect on the prescription of antibiotics, with some trials showing an increase
in antibiotic prescription and some showing a decrease (very low quality evidence).
Use of RDTs did not result in more patients with malaria being incorrectly diagnosed as not having malaria and being sent home
without treatment (low quality evidence).
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
RDT diagnosis versus clinical diagnosis for managing patients with fever in malaria endemic settings
Patient or population: People with fever
Settings: Malaria endemic settings
Intervention: Algorithms that include malaria RDTs
Control: Algorithms based on clinical symptoms and signs only
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
Clinical diagnosis RDT diagnosis
Patients still unwell at day 4
to 7
83 per 1000 73 per 1000
(57 to 97)
RR 0.90
(0.69 to 1.17)
6990
(5 trials)
⊕⊕©©
low1,2,3,4
Patients prescribed anti-
malarials
940 per 1000 607 per 1000
(489 to 686)
RR 0.62
(0.52 to 0.73)
17,287
(7 trials)
⊕⊕⊕©
moderate1,5,6,7
Patients prescribed antibi-
otics
- - Not pooled 13,573
(5 trials)
⊕©©©
very low1,8,9
Patients with microscopi-
cally confirmed malaria not
receiving antimalarials
27 per 1000 32 per 1000
(17 to 62)
RR 1.21
(0.64 to 2.28)
1280
(1 trial)
⊕⊕©©
low10,11,12
*The basis for the assumed risk (e.g. the median control group risk across trials) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the
comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; HR: Hazard ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.3
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1 No serious risk of bias: None of these trials adequately described allocation concealment, however this was not downgraded.
2 No serious inconsistency: Statistical heterogeneity was low. However, in one trial health worker compliance with the RDT protocol was
very low, with a high prescription of antimalarials in both groups. This trial found no effect (RR 1.01), while in the remaining trials with
good compliance there is a trend towards benefit with RDTs.
3 Downgraded by one for serious indirectness: The only patients who could feasibly benefit from the use of RDT are patients with a
negative RDT whose fever is not due to malaria. The management protocol and advice given to health workers about how to manage
these patients in these trials is unclear and the effect of RDT use on antibiotic prescribing was highly varied. These five trials were
conducted in rural areas in Burkina Faso, Zambia, and Uganda (three trials). The health staff were community health workers, nurses or
clinical officers.
4 Downgraded by one for serious imprecision: There is a trend towards benefit with RDTs, however this does not reach statistical
significance, even when the trial with poor adherence to the RDT protocol was excluded.
5 Downgraded by one for serious inconsistency: The size of the reduction in antimalarial prescription varied according to HW compliance
with RDT results. In one trial from Burkina Faso, where HW prescribed high levels of antimalarials to negative RDTs, no difference in
antimalarial prescription was seen. In the remaining six trials HW compliance was much higher, and prescriptions lower
6 No serious indirectness; These trials were mainly conducted in rural settings in Africa, with a range of malaria endemicity.
7 No serious imprecision:. Statistically significant differences were seen in all six trials with moderate or high heathworker adherence
8 Downgraded by two for very serious inconsistency: There is a large range of effects both increasing and decreasing antibiotic use
across trials.
9 Downgraded by one for serious indirectness: The only patients who could feasibly benefit from the use of RDT are patients with a
negative RDT whose fever is not due to malaria. The management protocol and advice given to health workers about how to manage
these patients in these trials is unclear
10 No serious risk of bias: This trial was individually randomized and at unclear risk of selection bias.
11 Downgraded by one for serious indirectness: Only one trial conducted microscopy on all participants. This trial was conducted in
Ghana in an area of unclear endemicity. The number of missed diagnoses is likely to vary with malaria endemicity. In the three trials
from Uganda which only conducted microscopy on participants in the RDT arm: the negative predictive value was 0.96 in the very high
endemic setting, 0.97 in the high endemic setting, and 0.93 in the medium endemic setting.
12 Downgraded by one for serious imprecision: The 95% CI is wide including what may be clinically important increase in missed cases.
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B A C K G R O U N D
Description of the condition
Malaria is a febrile illness, caused by infectionwith thePlasmodium
parasite, and is spread fromperson to person by the bite of infected
Anopheles mosquitoes. Five Plasmodium species infect humans, of
which Plasmodium falciparum is the most common in Africa and
responsible for most of the severe disease cases (WHO 2012).
’Uncomplicated’ malaria is the mild form of the disease which
commonly presents as a fever. Light microscopy is the gold stan-
dard for confirming the diagnosis by detecting parasites in the
symptomatic person’s blood (WHO 2010a). However, the vast
majority of malaria episodes and deaths occur in rural parts of
Africa where diagnostic services are limited. Consequently di-
agnosis of malaria has often relied on clinical symptoms alone
(D’Acremont 2009; English 2009).
Description of the intervention
Rapid diagnostic tests (RDTs) are individual test kits that can de-
tectPlasmodium-specific antigens in a drop of fresh bloodusing lat-
eral flow immunochromatography (WHO2006;Wongsrichanalai
2007). RDTs offer a feasible alternative to microscopy, particu-
larly for rural first-level health facilities, as they do not require a
laboratory or special equipment, are simple to use with relatively
little training, and provide a positive or negative result within 20
minutes (Wongsrichanalai 2007).
Two RDT types are in common use; 1) HRP-2; which detects a
histidine-rich protein produced by P. falciparum, and 2) pLDH;
which detects the parasite lactate dehydrogenase (pLDH) enzymes
produced by all species of Plasmodium that cause malaria in hu-
mans (WHO2010b;Wongsrichanalai 2007). ACochrane Review
of the diagnostic test accuracy of RDTs concluded that both tests
were highly sensitive (having few false negative results) and highly
specific (having few false positive results); HRP-2: sensitivity =
95.0%, specificity = 95.2%; pLDH: sensitivity = 93.2%, speci-
ficity = 98.5% (Abba 2011).
Interventions to introduce RDTs are usually multifactorial includ-
ing: in-service training and supervision of health workers, and dis-
semination of written guidelines or protocols, as well as introduc-
tion of the test itself. These supplementary interventions are nec-
essary to assure adherence to diagnostic and treatment algorithms,
and appropriate use of the RDT device under field conditions.
How the intervention might work
The clinical symptoms associated with malaria are poor predic-
tors of the disease. Reliance on clinical signs alone results in sig-
nificant overuse of antimalarials, with between 32% and 93% of
patients being falsely diagnosed with malaria, dependent on the
local malaria endemicity (Koram 2007; Rolland 2006; Zikusooka
2008). The introduction of RDTs to improve malaria diagnosis
therefore has the potential to substantially reduce the over-pre-
scription of antimalarial drugs, by reducing themisclassification of
fevers, especially in low prevalence areas (Lubell 2007; Zikusooka
2008; Zurovac 2008). However, for patients that have malaria as
the true cause of their fever, RDT introduction is unlikely to im-
prove their health outcomes, as they would receive antimalarials
even under an algorithm based on clinical symptoms (see Figure
1). Instead, the potential health benefits of introducing RDTs are
restricted to people whose fever is not due to malaria, for whom a
negative RDT result should prompt the health worker to look for
and treat the true cause of their fever. RDT introduction also has
the potential for harm when false negative RDT results misclassify
patients as not having malaria and consequently the appropriate
antimalarial is not given or is delayed (D’Acremont 2009; Graz
2011; Talisuna 2007; WHO 2010a).
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Figure 1. Logic framework for predicting the effect on health outcomes of using a HRP-2 RDT with 95%
sensitivity and 95.2% specificity (Abba 2011).
Basic modelling, using the sensitivity and specificity of the HRP-
2 RDT gained from a Cochrane Review (Abba 2011), predicts
that areas of low malaria transmission have the greatest potential
for health benefits as a result of introducing RDTs, and the lowest
potential for harm from false negatives (see Figure 1). However,
some suggest that in very low transmission settings where clini-
cal malaria can occur at parasite densities lower than 100 para-
sites/µL of blood, RDTs may have lower sensitivity and lead to
higher numbers of false negatives (English 2009; Murray 2008;
Wongsrichanalai 2007).
Widespread overuse of antimalarials is also thought to contribute
to the development and spread of antimalarial resistance, and re-
ductions in overuse through the use of RDTs could contribute to
limiting this risk (Shillcutt 2008).
Why it is important to do this review
The World Health Organization now recommends that all sus-
pected malaria cases receive a parasitological diagnosis prior to
treatment (WHO 2010a), and RDTs are the most feasible way of
achieving this in rural areas of Africa (D’Acremont 2009; WHO
2006; WHO 2010a).
For policy makers seeking to introduce and improve malaria di-
agnosis in rural settings, this review aims to evaluate the effect of
introducing RDTs into clinical algorithms on both the health out-
comes for patients, and the unnecessary overuse of antimalarials.
For health workers working in rural areas, this review also aims to
evaluate the safety of RDT-supported algorithms, and the poten-
tial for patients to be misdiagnosed as non-malaria and sent home
without appropriate treatment.
O B J E C T I V E S
To evaluate whether introducing RDTs into algorithms for diag-
nosing and treating people with fever improves health outcomes,
reduces antimalarial prescribing, and is safe compared to algo-
rithms using clinical diagnosis.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Individual or cluster randomized controlled trials (RCTs).
Types of participants
Patients with fever, or a reported history of fever, living in malaria
endemic areas.We excluded trials conducted in non-endemic areas
(for example, fever in travellers in Europe).
Types of interventions
Intervention
Diagnostic algorithms using RDTs to determine treatment for
fever.
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Control
Diagnostic algorithms based on clinical diagnosis to determine
treatment for fever.
Types of outcome measures
Clinical
• Patients still unwell at day 4+ follow-up.
Prescribing
• Patients with fever prescribed antimalarials.
• Patients with fever prescribed antibiotics.
Safety
• Microscopy-positive patients not prescribed antimalarials.
• Microscopy-negative patients prescribed antimalarials.
Search methods for identification of studies
We attempted to identify all relevant trials regardless of language
or publication status (published, unpublished, in press, and on-
going).
Electronic searches
We searched the following databases up to 10 January 2014 using
the search terms described in Appendix 1: Cochrane Infectious
Disease Group Specialized Register; Cochrane Central Register of
Controlled Trials (CENTRAL), published in The Cochrane Li-
brary; MEDLINE; EMBASE; CINAHL; and LILACS.
In addition we searched the metaRegister of Controlled Trials
(mRCT) and theWHO trials register using “malaria” AND“rapid
diagnostic test*” OR “presumptive treatment” as search terms.
Searching other resources
Researchers and organizations
We contacted researchers in the field to identify additional trials
that may have been eligible for inclusion.
Reference lists
We checked the reference lists of all selected trials identified by the
search strategy described above.
Data collection and analysis
Selection of studies
John Odaga (JO) and Joseph A. Lokong (JAL) independently
screened the abstracts in the search list for potentially relevant tri-
als. We compared the list of potential articles independently iden-
tified by both authors. JO retrieved the full texts of the selected
trials, which were made available to both authors. Both JO and
JAL independently assessed each trial for inclusion, using an eli-
gibility form based on the inclusion criteria. We included a trial if
it satisfied all of the eligibility criteria. We resolved any disagree-
ments by referring to the original articles or through discussions,
or both, and where necessary by consulting Paul Garner (PG) and
Sarah Donegan (SD).
Data extraction and management
JO and PG independently extracted outcomes data from the in-
cluded trials, guided by a standard data extraction form. We re-
solved any disagreements by referring to the original paper and
through discussions.Where necessary, we sought clarification from
trial authors by contacting them directly to provide relevant data
missing from the included trials (for example, number of partici-
pants by age group, number of health centres excluded from anal-
ysis).
Assessment of risk of bias in included studies
JO and PG independently assessed and judged the quality of the
selected papers using the standard criteria (Higgins 2011). We as-
sessed risk of bias against seven items: (1) how allocation sequence
was generated (2) how allocation was concealed to participants, in-
vestigators and outcome assessors; (3) blinding of participants and
investigators; (4) blinding of outcome assessors; (5) completeness
of outcomes data (number analysed relative to number random-
ized) (6) selective reporting: whether all pre-specified outcomes
are reported; and (7) other sources of bias.
Measures of treatment effect
For all the included outcomes we calculated a risk ratio (RR) and
presented the results alongside the 95% confidence interval (CI).
Unit of analysis issues
We performed analyses of all outcomes at individual levels using
generic inverse variance method. Five of the included trials were
cluster RCTs in which the unit of randomization were health fa-
cilities but analyses were performed at patient level.
Where trial authors had adjusted their results for the effect of clus-
tering, we extracted the cluster adjusted RR and standard error and
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entered the natural log of these into Review Manager (RevMan)
using the generic inverse variance method as recommended by
Higgins 2011.
Where trial authors had not adjusted their results for the effect
of clustering, we extracted the simple summary data for all rele-
vant outcomes and calculated crude RR & 95% CI using Review
Manager (RevMan).We adjusted for the effects of clustering using
the approximate analysis method (as described in Higgins 2011).
This involves inflating the standard error of the RR using an es-
timate of the design effect, and entering the natural logs of the
adjusted RR and corresponding Standard Errors (SE) into Review
Manager (RevMan) using the generic inverse variancemethod. For
measures of antimalarial and antibiotic prescribing, we applied an
external design effect of 3.8, as recommended by Rowe 2002 for
health facility surveys assessing antimalarial treatment in Benin.
For other measures we used the design effect stated by the trial
authors when calculating their sample size.
When trial authors had correctly adjusted their results for the effect
of clustering, but presented their results asOddsRatio (OR) rather
than Risk Ratio (RR), we again extracted the simple summary data
and conducted our own approximate adjustment for clustering as
described above.
One trial was a cluster RCTwith three clusters per group (Hopkins
2008 UGA (Medium), Hopkins 2008 UGA (High), Hopkins
2008 UGA (V High)). However, we presented the data stratified
by malaria endemicity where there was only one cluster per group.
As a consequence, we could not make any adjustment for cluster-
ing. However, any clustering effect is likely to be very small, and
unlikely to substantially affect the result or our interpretation.
Assessment of heterogeneity
We assessed heterogeneity among trials by inspecting the forest
plots for overlapping CIs. We also applied the Chi2 test for het-
erogeneity with a 10% level of statistical significance, and an I2
statistic value greater than 40% to denote moderate levels of het-
erogeneity (Higgins 2011).
Data synthesis
We analysed the data using Review Manager (RevMan).
Where we had pooled data we used the generic inverse variance
method which allows for meta-analysis of both individually and
cluster randomized trials. When we detected moderate levels of
heterogeneity we combined trials using the random-effects model
which assumes the trials are estimating different, but related, in-
tervention effects (Higgins 2011).
Quality of evidence
We assessed the quality of evidence across each outcome measure
using the GRADE approach. The quality rating across trials has
four levels: high, moderate, low, or very low. RCTs are initially
categorized as high quality but can be downgraded after assessment
of five criteria: risk of bias, consistency, directness, imprecision,
and publication bias (Guyatt 2008).
Subgroup analysis and investigation of heterogeneity
Where we detected moderate heterogeneity, we performed sub-
group analyses by stratifying results by the level of health worker
adherence to the RDT result, the level of malaria endemicity, and
the age group of the targeted population.
R E S U L T S
Description of studies
Results of the search
From the search strategy, we identified a total 273 abstracts of trial
reports (after removal of duplicates) and ten records of ongoing
trials (see Figure 2 for the study flow diagram). We did not deem
any of the ongoing trials relevant to this review.
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Figure 2. Study flow diagram.
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Included studies
We included seven RCTs that enrolled 17,505 participants; two
individually RCTs (Ansah 2010 GHA; Bisoffi 2009 BFA), two
published cluster-RCTs (Skarbinski 2009 KEN; Yeboah-Antwi
2010 ZAM), and three unpublished cluster-RCTs (Hopkins 2008
UGA (VHigh);Hopkins 2008UGA (High);Hopkins 2008UGA
(Medium)). For a summary of the trial characteristics see Table 1,
and for full details of individual trials see the ’Characteristics of
included studies’ tables.
Setting
All seven RCTs were conducted in Africa, in rural areas of Ghana,
Burkina Faso, Zambia, Kenya, and Uganda. All trials were under-
taken in basic healthcare facilities withoutmicroscopes. The health
workers responsible for diagnosing and treating patients with fever
were community health workers in one trial (Yeboah-Antwi 2010
ZAM), nurses In two trials (Ansah 2010 GHA; Bisoffi 2009 BFA),
and a mix of clinical officers and nurses in four trials (Hopkins
2008 UGA (VHigh);Hopkins 2008 UGA (High);Hopkins 2008
UGA (Medium); Skarbinski 2009 KEN).
Regarding malaria endemicity, Ansah 2010 GHA did not describe
it, Bisoffi 2009 BFA described it as seasonal, and Skarbinski 2009
KEN and Yeboah-Antwi 2010 ZAM described it as a mix of ’high
and low’. The three trials fromUganda were conducted in areas of
’very high’, ’high’ and ’medium’ endemicity respectively (Hopkins
2008 UGA (VHigh);Hopkins 2008 UGA (High);Hopkins 2008
UGA (Medium)). For subgroup analyses by endemicity we have
used the proportion of RDTs testing positive as a surrogate marker
for endemicity rather than these vague descriptors.
Interventions
The intervention consisted of training health workers to diagnose
and treat patients with fever using clinical protocols incorporating
RDTs. The duration of training was short (ranging from one half
day in Kenya to five days in Zambia), and the level of ongoing
supervision varied between trials (see Table 2). Supportive super-
vision (observation of tasks with feedback) was provided monthly
in Zambia, and once in Kenya (two months after training). In
Uganda, no formal supervision was provided, and in Ghana and
Burkina Faso the level of supervision was unclear.
In two trials, members of the research team conducted the RDT
tests and then sent the results to the health workers for interpre-
tation and treatment (Ansah 2010 GHA; Bisoffi 2009 BFA). The
authors state that this approach aimed to optimise the quality of
RDT results and minimise time pressure on the health workers.
In the Zambian, Kenyan, and Ugandan trials, the clinical officers,
nurses or community health workers carried out the test them-
selves.
Only four trials reported to have provided written guidelines to
the intervention health facilities following training (Hopkins 2008
UGA (V High); Hopkins 2008 UGA (Medium); Hopkins 2008
UGA (High); Skarbinski 2009 KEN), and only five trials included
in their training a clear message about the need for health workers
to look for alternative causes of fever in patients with negative
RDTs (Bisoffi 2009 BFA;Hopkins 2008UGA (VHigh);Hopkins
2008 UGA (Medium); Hopkins 2008 UGA (High); Skarbinski
2009 KEN).
RDTs, antimalarials, and antibiotics were provided to patients free
of charge in all trials.
Adherence to algorithm
Only the three trials from Uganda provide data on the extent to
which RDTs were conducted in the intervention arm. In these
trials, at least 97% of all fever cases were tested by RDTs to con-
firm the presence of malaria prior to treatment (Hopkins 2008
UGA (VHigh);Hopkins 2008UGA (High);Hopkins 2008UGA
(Medium)). Six trials provide data on the proportion of RDT-pos-
itive patients for whom antimalarials were prescribed (see Table
3). Health workers prescribed antimalarials to 98% to 100% of
cases with positive RDTs, and to up to 81% of patients with neg-
ative RDTs. Where this is likely to have affected the outcome we
conducted subgroup analyses by level of health worker adherence.
Participants
One trial targeted children under the age of five years (Yeboah-
Antwi 2010 ZAM), one trial targeted older children (Skarbinski
2009 KEN), and five trials targeted all age groups. All trials re-
cruited participants with fever or history of fever except the three
unpublished trials which recruited participants with any com-
plaint. However, for these unpublished trials we restricted our
analysis to only the subgroup of participants which presented with
fever.
Excluded studies
We excluded seven trials and listed the reasons in the
Characteristics of excluded studies table.
Risk of bias in included studies
We have presented a summary of the risk of bias assessment in
Figure 3.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
trial.Green = low risk of bias, red = high risk of bias, yellow = unclear risk of bias.
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Allocation
Only one trial adequately described both sequence generation and
allocation concealment to be considered at low risk of selection
bias (Ansah 2010 GHA). The remaining six trials were at unclear
risk due to inadequate descriptions of allocation concealment.
Blinding
Blinding of participants and health workers to the use of RDTs
was not be possible. However, blinding of the outcome assessment
was possible in all trials but was not described in any of them.
Incomplete outcome data
Attrition bias was at low risk of bias (≤ 3%) in six trials, and in
one trial the attrition rate was high (30%) and unequal in the two
arms (Skarbinski 2009 KEN).
Selective reporting
All trials reported outcomes that were pre-specified in the meth-
ods sections of their protocols and reports. The risk of selective
reporting was low.
Other potential sources of bias
Three trials (Ansah 2010 GHA; Skarbinski 2009 KEN; Yeboah-
Antwi 2010 ZAM) acknowledged baseline imbalance in the num-
ber or quality of the health workers enrolled into the trial, which
were adjusted for using different methods.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings table
See Summary of findings for the main comparison for a summary
of the results and GRADE appraisal of the quality of evidence.
Clinical outcomes
Patients still unwell at day 4+ follow-up
Five trials from settings with very high, high, andmoderatemalaria
endemicity, reported the proportion of patients who were still
unwell four to seven days after treatment, and found no significant
differences between clinical and RDT-supported diagnosis (RR
0.90, 95% CI 0.69 to 1.17, 6990 participants, five trials, Analysis
1.1, Figure 4). The absolute numbers of participants remaining
unwell ranged from 2.8 to 9.3% in those diagnosed with an RDT,
and from 4.1 to 10.8% in those diagnosed clinically (see Appendix
2).
Figure 4. Forest plot of comparison: 1 RDT-supported diagnosis versus Clinical diagnosis, outcome: 1.1
Patients still unwell at follow-up at day 4+.
Statistical heterogeneity was low (I2 = 0%). However, in one trial
health worker compliance with the RDT-supported diagnosis was
very low, with a high prescription of antimalarials in both groups
regardless of the RDT result (Bisoffi 2009 BFA). This trial found
no difference between the intervention arms in the proportion of
cases who were still unwell at follow-up (2095 participants, one
trial, Analysis 1.2). In the remaining trials with improved health
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worker compliance, there is a trend towards a health benefit with
using RDTs, although the CI is wide and includes the possibility
of no difference between groups (4895 participants, four trials,
Analysis 1.2).
Prescribing outcomes
Patients with fever prescribed antimalarials
Although fewer patients in the group with RDT-supported di-
agnosis were prescribed antimalarials there is substantial hetero-
geneity between trials, with no impact on prescribing in one trial
and moderate or large effects in the others (17,287 participants,
seven trials, I² = 98%, Analysis 1.3). This variation seems most
related to health worker adherence to the RDT-supported pro-
tocol (Figure 5). In the trial from Burkina Faso health workers
prescribed antimalarials to 81% of patients with negative RDT
results, and consequently no difference in antimalarial prescribing
was detected (RR 1.02, 95% CI 0.99 to 1.06, 2169 participants,
one trial, Analysis 1.4). In the four trials in which health worker
adherence was high, the reduction in prescribing of antimalarials
was large (Analysis 1.4, Figure 5).
Figure 5. Forest plot of comparison: 1 RDT-supported diagnosis versus Clinical diagnosis, outcome: 1.4
Patients with fever prescribed antimalarials; subgrouped by health worker adherence to the RDT result.
Within the subgroup of trials with high health worker adherence,
the relative malaria endemicity also seems to influence the size of
the reduction in antimalarial prescriptions. The biggest reductions
were seen where less than 30% of people presenting with fever
tested positive by RDT, and smaller reductions were seen where
RDTpositivitywas greater than40%, or greater than70%(11,007
participants, four trials, Analysis 1.5).
We also conducted a subgroup analysis by age of participants, and
the reduction in antimalarial use appears largest in participants
over the age of five (Analysis 1.6).Wewere unable to assess whether
this difference was due to reduced health worker adherence when
treating children aged less than five as the data were unavailable.
Patients with fever prescribed antibiotics
Five trials reported the proportion of patients prescribed antibi-
otics with very variable results (13,573 participants, five trials,
Analysis 1.7).
In Burkina Faso, where compliance with the RDT result was
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very low and no difference was seen in antimalarial prescribing
behaviour, there was also no difference in antibiotic prescribing
(Bisoffi 2009 BFA, Analysis 1.7). In the two trials with the largest
relative reduction in antimalarial prescribing, there was no signifi-
cant difference in antibiotic prescribing between groups ((Hopkins
2008UGA (Medium);Hopkins 2008UGA (High), Analysis 1.7).
In these trials, the RDT protocol did not recommend antibiotics
for all RDTnegative patients but instead advised the health worker
to look for other causes of fever and treat appropriately.
In the Uganda setting with very high endemicity, where over 70%
of RDTs were positive, and antimalarial prescribing was reduced
by a quarter the RDT protocol also reduced antibiotic prescrib-
ing (Hopkins 2008 UGA (V High), Analysis 1.7). Conversely, in
Ghana where 63% of RDTs were positive and antimalarial pre-
scribing was also reduced by a quarter, antibiotic prescribing in-
creased in the RDT group (Ansah 2010 GHA, Analysis 1.7).
Safety outcomes
Microscopy positive patients not prescribed antimalarials
Only one trial conducted microscopy on all participants in both
intervention arms allowing identification of malaria cases ’missed’
by the RDT-supported protocol, or ’false negatives’ (Ansah 2010
GHA). This trial was conducted in Ghana where 63% of RDTs
were positive for malaria. The proportion of reference slide posi-
tive patients not prescribed antimalarials was higher with the use
of RDTs but this did not reach statistical significance (1280 par-
ticipants, one trial, Analysis 1.8).
In addition, the three trials from Uganda conducted microscopy
on just the participants in the arms using RDT-supported diag-
nosis. The proportion of microscopy positive patients not given
antimalarials due to a negative RDT result was 2.0% in the very
high endemic setting (95% CI 1.2% to 2.8%, 1187 participants),
4.5% in the high endemic setting (95% CI 2.3% to 6.6%, 357
participants), and 17.2% in the area of medium endemicity (95%
CI 11.6% to 22.8%, 174 participant). Table 4 examines how these
figures translate into negative and positive predictive values in the
different settings. In the area of medium endemicity, the accuracy
of RDTs performed by health workers was not as high as in settings
of high and very high endemicity with a sensitivity of 82.8%, and
specificity of 72.2%. Consequently, the negative predictive value
of a negative RDT in this setting is 0.93, which means that for
every 100 patients with a negative RDT result, seven patients will
have malaria parasites demonstrated by microscopy (false nega-
tives).
Microscopy negative patients prescribed antimalarials
The same trial from Ghana also allows identification of ’false pos-
itives’; the number of patients without malaria on microscopy
who tested positive by RDT and received antimalarials (Ansah
2010 GHA). In this trial RDT-supported diagnosis significantly
reduced the over treatment of malaria (RR 0.60, 95% CI 0.57
to 0.64, 2162 participants, one trial, Analysis 1.9), but 53.9% of
people with negative microscopy still received antimalarials.
In the three trials from Uganda, which conducted microscopy on
just the participants in the arms using RDT-supported diagnosis,
the proportions of slide negative participants who were prescribed
antimalarials because they tested positive on RDT (false positives)
was 34.4% in themedium transmission setting (95%CI 29.9% to
39.0%, 418 participants), 15.2% in the high transmission setting
(95% CI 12.4% to 18.1%, 617 participants), and 43.9% in the
very high transmission setting (95% CI 40.8 to 46.9%, 1028
participants).
D I S C U S S I O N
Summary of main results
Seven trials, enrolling 17,505 participants, are included in this
review; two individually RCTs and five cluster RCTs.
In most trials the health workers diagnosing and treating malaria
were nurses or clinical officers who had undergone less than one
week of training in RDT supported diagnosis. Health worker ad-
herence to the RDT result was highly variable, with the percent-
age of participants with a negative RDT result who received anti-
malarials ranging from 0% to 81%.
In these trials, RDT-supported diagnosis had little or no effect on
the number of participants remaining unwell at four to seven days
after treatment (low quality evidence).
However, using RDTs reduced the prescription of antimalarials by
up to three-quarters (moderate quality evidence), and as would be
expected reductions in prescribing of antimalarials were highest
where health workers adherence to the RDT result was high, and
where the true prevalence of malaria was lower.
Using RDTs to support diagnosis did not have a consistent effect
on the prescription of antibiotics with some trials showing an
increase in antibiotic prescription and some showing a decrease
(very low quality evidence).
In a single trial from a setting with moderate endemicity, which
reported microscopy results for all enrolled patients, RDT sup-
ported diagnosis did not result in a statistically significant excess
of patients with microscopically confirmed malaria who did not
receive antimalarials (low quality evidence).
Overall completeness and applicability of
evidence
The included trials were all conducted in first-level health facilities
in rural areas of Africa, where the majority of malaria cases occur,
and where RDTs offer the only feasible alternative to presumptive
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treatment ofmalaria based on clinical symptoms alone.These trials
are from settings with a range of levels of malaria endemicity, and
the findings could reasonably be applied to other similar African
settings.
The main concern of health workers regarding the use of RDTs
is the risk of missing malaria cases and sending children home
without antimalarials when the result of the RDT is a false negative
(D’Acremont 2009; English 2009;Murray 2008;Wongsrichanalai
2007). Reassuringly, this review found no difference in patient
health outcomes when RDTs are introduced, and the trend is
in the direction of benefit. However, only one trial adequately
evaluated the risk of false negative results by applying the gold
standard light microscopy to all fever patients in both treatment
arms (Ansah 2010 GHA), and although the result did not reach
statistical significance the trend was towards higher numbers of
missed cases when RDTs were used.
The additional trial fromUganda, which reported decreased RDT
sensitivity in the setting with lowest endemicity adds to this con-
cern. In this setting, of 404 patients with negative RDTs, 30 (7%)
hadmalaria parasites following microscopy analysis. This risk may
be considered too high by some patients and health workers unless
adequate measures are taken to ensure the safety of these patients,
such as routine follow-up at 24 or 48 hours and repeat testing
if they remain unwell. These data also raise concerns about the
performance of RDTs in real-life clinical scenarios. The cause of
the low sensitivity is not clear, and may be user-dependent, but
reassuringly this trial appears to be an outlier when seen in the
context of all the observational data on RDT sensitivity and speci-
ficity (see Figure 6). Of the 71 trials of HRP-2 RDTs included in
the Cochrane diagnostic test accuracy review, 51 were conducted
in areas of lower endemicity with a pooled sensitivity of 95.1%
(95% CI 93.1 to 96.6) and specificity of 95.9% (95% CI 94.1 to
97.2) (Abba 2011).
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Figure 6. Sensitivity and specificity of 71 trials of HRP-2 RDTs included in the Cochrane Review of RDTS for
diagnosing P. falciparum malaria (Abba 2011). The data from Hopkins 2008 UGA (Medium) is represented
with a blue circle at sensitivity 0.829 and specificity 0.894.
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The five trials included in this review show no clear trend in pre-
scribing of antibiotics which may indicate inconsistency in proto-
cols for managing RDT negative results. This is surprising given
that those with negative RDTs are the only people who will po-
tentially benefit from the introduction of RDTs and also those
who will potentially be harmed. Future research, and future pro-
grammes, should concentrate on improving health worker guid-
ance and patient health outcomes in this group.
Quality of the evidence
We assessed the quality of the evidence using the GRADE ap-
proach and presented the basis for the judgements in Summary of
findings for the main comparison.
The evidence that introducing RDTs has little or no effect on
health outcomes is of low quality, meaning we can only have lim-
ited confidence in this result. Although there were minor concerns
about risk of bias (with none of the trials adequately minimis-
ing the risk of selection bias), and inconsistency (with one trial
with very poor health worker adherence finding no evidence of
an effect), the main reasons for downgrading the evidence were
’indirectness’ and ’imprecision’. The evidence is indirect because
health benefits of introducing RDTs will only be seen with ade-
quate treatment of the fevers not caused by malaria. In these trials,
the management protocol for patients with negative RDTs was
unclear, and the mixed effects on antibiotic prescribing may sug-
gest that the management of these patients was erratic. Once we
excluded the trial with poor health worker adherence (Bisoffi 2009
BFA), there was a consistent trend towards benefit with the use of
RDTs although this did not reach statistical significance. Larger
trials may be necessary to show statistically significant benefits if
they exist.
The evidence that introducing RDTs can substantially reduce the
overuse of antimalarials is of moderate quality, meaning we can
have reasonable confidence in this result. We downgraded the ev-
idence due to concerns about inconsistency between trials, with
large effects in some and complete absence of effects in others.
This inconsistency is best explained by the variation in adherence
of health workers to negative RDT results. Consequently, to see
the reductions in antimalarial use predicted by the known malaria
prevalence in any setting, healthcare managers will need to ensure
adequate training, support, and supervision for health workers in
the use of RDTs, and in the management of patients who test
negative.
The evidence that using RDTs does not increase the proportion
of patients with malaria who are sent home without antimalarials
is of low quality, meaning we can have only limited confidence in
this result. This result is from a single trial setting, and was down-
graded for serious indirectness as the result is poorly applicable to
elsewhere. The 95% CI is also wide and includes the possibility of
clinically important harms with RDTs and was downgraded for
serious imprecision.
Potential biases in the review process
We have reported the RDT sensitivity and specificity of a single
arm from a trial at three sites in Uganda because this data was
available to us (Hopkins 2008 UGA (V High); Hopkins 2008
UGA (High); Hopkins 2008 UGA (Medium)). However, this in-
formation is observational, and in this review we did not search
for all trials that would present this information. These data there-
fore should only be considered in the context of the wider body
of evidence included in the Cochrane Review by Abba 2011.
Agreements and disagreements with other
studies or reviews
The review results are supported by findings from several quasi-
experimental and observational studies excluded from this review.
For health outcomes, two weekly cross-over trials from Tanzania
found no change in mortality with the introduction of RDTs.
However, in one of these studies RDTs were associated with a de-
crease in the proportion of patients remaining unwell two weeks
after treatment (Msellem 2009), and in the other RDTs were as-
sociated with an increase in the proportion still unwell after seven
days of treatment (Mubi 2011).
For prescribing outcomes, several non-RCTs have found re-
ductions in antimalarial prescribing following the introduction
of RDTs, especially in low transmission areas (Yukich 2012;
D’Acremont 2011; Kyabayinze 2010; Msellem 2009; Reyburn
2007). Routine data from a large scale implementation project in
Senegal found similar results over a three year period providing
some evidence that RDTs reduce prescribing of antimalarials in
routine practice as well as under experimental conditions (Thiam
2011).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Algorithms incorporating RDTs can substantially reduce anti-
malarial prescribing if health workers adhere to the test results.
The introduction of RDTs has not been shown to improve health
outcomes for patients but adherence to the test result does not
seem to result in worse clinical outcomes than presumptive treat-
ment. Concentrating on improving the care of RDT negative pa-
tients could improve health outcomes in febrile children.
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These trials were performed as these new RDT technologies were
being rolled out, so observational studies and audits of guideline
implementation will help monitor adherence over time.
Implications for research
Decision making around the use of RDTs could be further in-
formed by:
• Continued evaluation of RDT sensitivity under operational
conditions in settings with moderate or low endemicity,
• Better quantification of the risk of patient harm to those
with false negative RDT results,
• Better quantification of the causes of non-malaria fevers in
these settings,
• Design and evaluation of interventions aimed at improving
the care of RDT negative patients such as improved protocols
which include routine follow-up or repeat RDT testing at 24 to
48 hours if patients remain unwell.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ansah 2010 GHA
Methods Trial design: individually RCT
Patients evaluated on day 28
Reference slides taken on all patients
Participants Children and adults with suspected malaria
Exclusion: pregnancy, illness requiring admission, non-compliance with allocated test or
treatment, not living locally
Number of participants randomized: 3452
Number analysed for primary outcome (prescribing of antimalarials): 3442 (0.3% loss
to follow-up)
Interventions RDT plus treatment versus clinical diagnosis plus treatment.
(A second component examiningRDTversusmicroscopy did notmeet our entry criteria)
Health workers in both groups received training and held guidelines
RDT performed by research team
Health workers complied with guidelines partially: 49.5% of participants with negative
RDT results received antimalarials
Outcomes Primary:
Patients treated with antimalarials who did not have malaria based on reference slide
Secondary:
1. Patients not receiving antimalarial treatment who were malaria reference slide
positive.
2. Patients prescribed antibiotics
3. Patients with positive reference slide not prescribed antimalarials
4. Patients correctly treated (patients that were reference slide positive and treated
with antimalarials plus patients that were reference slide negative and not prescribed
antimalarial treatment)
Notes Country: Ghana
RDT: OptiMAL-IT
Setting: three health centres, of all referral levels
Transmission: not indicated
Dates: July 2007 to December 2008
Funding: Gates Malaria Partnership
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated blocks of 10.
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Ansah 2010 GHA (Continued)
Allocation concealment (selection bias) Low risk Numbers placed in sealed opaque en-
velopes.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Trial participants and staff were aware of
allocated tests, the results, andprescriptions
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Both the trial participants and personnel
were aware of the diagnostic outcomes and
the medications prescribed
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up was low and comparable
in both settings (≤ 3%)
Selective reporting (reporting bias) Low risk Reported on all - outcomes specified in
prospective trial register
Other bias Low risk No other sources of bias identified.
Bisoffi 2009 BFA
Methods Trial design: individually RCT
lasting two months, one month in rainy season, one month in dry season
Participants Number of participants randomized: 2169 (1058 in RDT arm, 1111 in presumptive
treatment arm)
Number analysed for primary outcomes: (a) prescribing of antimalarials analysis 2169
(0% loss); (b) clinical outcomes: 2095 (3.4% loss)
Inclusion: age ≥ 6 years; axillary temperature ≥ 37.5°C
Exclusion: severe malaria
Interventions Intervention: RDT-based policy for fever
Control: Presumptive treatment
Both groups received training and held guidelines
RDT performed by research team
Health workers did not comply with guidelines most of the time: 81% of participants
with negative RDT results received antimalarials
Outcomes Primary: patients with fever on day 4
Secondary:
1. patients still experiencing other symptoms on day 4;
2. patients given antimalarials
3. patients given antibiotics
Notes Country: Burkina Faso
RDT: paracheck (HRP2)
Setting: peripheral health centres.
Sampling: convenient selection of health centres to ensure rural/urban representativeness
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Bisoffi 2009 BFA (Continued)
Transmission: stable with seasonal transmission
Dates: 2006; end of dry season and rainy season
Funding: UNIDEA-UNICREDIT Foundation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated random list.
Allocation concealment (selection bias) Unclear risk Not indicated.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Both the trial participants and personnel
were aware of intervention allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Both the trial participants and personnel
were aware of the diagnosis made and treat-
ment prescribed
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-upwas generally low (95.4%
dry season; 97.3% rainy season) but not
differentiated by trial group
Performed available case analysis, although
reported to have performed intention-to-
treat analysis
Selective reporting (reporting bias) Low risk Reported on all trial outcomes described in
the methodology.
Other bias Low risk No other sources of bias identified.
Hopkins 2008 UGA (High)
Methods Trial design: cluster randomized pre-post open-label trial; data included in this review
are from the two months following introduction of RDTs to the intervention arm
Participants Number of participants randomized: total fever cases 2213 (1073 in RDT arm, 1140 in
presumptive treatment arm);
Number of participants randomized for clinical outcomes was 25% of total fever cases,
553 (268 versus 285 respectively)
Number of participants analysed for primary outcomes: (a) prescribing of antimalarials
analysis 2213 (0% loss); (b) clinical outcomes: 483 (12.7% loss: 19.5% in intervention
arm versus 6.3% in presumptive treatment arm)
Inclusion: Any patient deemed eligible for RDT testing by the healthworker
Exclusion: None
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Hopkins 2008 UGA (High) (Continued)
Interventions Intervention: Training in fever case management based on RDTs
Control: Standard-of-care symptom-based or empiric treatment of fever
The intervention group received training and RDTs; one-day follow-up support su-
pervision was conducted two weeks after the initial three-day training. Data collection
commenced after the follow-up support supervision visit. The control group continued
usual symptom-based care according to existing Uganda Ministry of Health guidelines
RDT performed by treating clinician (usually clinical officer or nursing staff )
No other formal supervision was provided.
Outcomes Primary: patients with fever on day 4
Secondary:
1. patients still experiencing other symptoms on day 4;
2. patients given antimalarials;
3. patients given antibiotics.
Notes Country: Uganda
RDT: paracheck (HRP2)
Setting: peripheral health centres
Sampling: Lack of microscopy services, at least three full-time clinical staff, estimated
patient volume of at least 200 patients per week, willingness of health centre staff to
participate in the trial, and location within 20 km of a sentinel health centre established
by the Uganda Malaria Surveillance Project
Transmission: High; reference slide positivity in all participants with fever: 46%
Dates: 2008; first half
Funding: Exxon Mobil Corp. via the Academic Alliance Foundation; and NIH, USA,
K23 AI065457-01
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Coin flip in the presence of health centre
leaders.
Allocation concealment (selection bias) Unclear risk Allocation of RDTs was decided by coin
flip in the presence of study staff and repre-
sentatives from eachmatched pair of health
centers
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Both the trial participants and personnel
were aware of intervention allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Both the trial participants and personnel
were aware of the diagnosis made and treat-
ment prescribed
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Hopkins 2008 UGA (High) (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up was low (0.0% for pre-
scribing of antimalarials; 12.7% for clinical
outcomes, differentiated by trial group)
Performed available case analysis.
Selective reporting (reporting bias) Low risk Reported on all trial outcomes described in
the methodology.
Other bias Low risk No other sources of bias identified.
Hopkins 2008 UGA (Medium)
Methods Trial design: cluster randomized pre-post open-label trial; data included in this review
are from the two months following introduction of RDTs in the intervention arm
Participants Number of participants randomized: total fever cases 1550 (602 in RDT arm, 948 in
presumptive treatment arm)
Number of participants randomized for clinical outcomes was 25% of total fever cases,
i.e.388 (151 versus 267 respectively)
Number of participants analysed for primary outcomes: (a) prescribing of antimalarials
analysis 1550 (0% loss); (b) clinical outcomes: 328 (15.4% loss: 6.3% in intervention
arm versus 21.1% in presumptive treatment arm)
Inclusion: Any patient deemed eligible for RDT testing by the healthworker
Exclusion: None
Interventions Intervention: Training in fever case management based on RDTs
Control: Standard-of-care symptom-based or empiric treatment of fever
The intervention group received training and RDTs; one-day follow-up support su-
pervision was conducted two weeks after the initial three-day training. Data collection
commenced after the follow-up support supervision visit. The control group continued
usual symptom-based care according to existing Uganda Ministry of Health guidelines
RDT performed by treating clinician (usually clinical officer or nursing staff )
No other formal supervision was provided.
Outcomes Primary: patients with fever on day 4
Secondary:
1. patients still experiencing other symptoms on day 4
2. patients given antimalarials
3. patients given antibiotics
Notes Country: Uganda
RDT: paracheck (HRP2)
Setting: peripheral health centres
Sampling: Lack of microscopy services, at least 3 full-time clinical staff, estimated patient
volume of at least 200 patients per week, willingness of health centre staff to participate
in the trial, and location within 20 km of a sentinel health centre established by the
Uganda Malaria Surveillance Project
Transmission: Medium; reference slide positivity in all participants with fever 32%
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Hopkins 2008 UGA (Medium) (Continued)
Dates: 2008; first half
Funding: Exxon Mobil Corp. via the Academic Alliance Foundation; and NIH, USA,
K23 AI065457-01
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Coin flip in the presence of health centre
leaders.
Allocation concealment (selection bias) Unclear risk Allocation of RDTs was decided by coin
flip in the presence of study staff and repre-
sentatives from eachmatched pair of health
centers
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Both the trial participants and personnel
were aware of intervention allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Both the trial participants and personnel
were aware of the diagnosis made and treat-
ment prescribed
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up was low (0.0% for pre-
scribing of antimalarials; 15.4% for clinical
outcomes, differentiated by trial group)
Performed available case analysis,
Selective reporting (reporting bias) Low risk Reported on all trial outcomes described in
the methodology
Other bias Low risk No other sources of bias identified
Hopkins 2008 UGA (V High)
Methods Trial design: cluster randomized pre-post open-label trial; data included in this review
are from the two months following introduction of RDTs in the intervention arm
Participants Number of participants randomized: total fever cases 4197 (2288 in RDT arm, 1909 in
presumptive treatment arm);
Number of participants randomized for clinical outcomes was 25% of total fever cases,
i.e. 1049 (572 versus 477 respectively)
Number analysed for primary outcomes: (a) prescribing of antimalarials analysis 4197
(0% loss); (b) clinical outcomes: 959 (8.6% loss: 0.2% in intervention arm versus 17.
2% in presumptive treatment arm)
Inclusion: Any patient deemed eligible for RDT testing by the healthworker
Exclusion: None
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Hopkins 2008 UGA (V High) (Continued)
Interventions Intervention: Training in fever case management based on RDTs
Control: Standard-of-care symptom-based or empiric treatment of fever
The intervention group received training and RDTs; one-day follow-up support su-
pervision was conducted two weeks after the initial three-day training. Data collection
commenced after the follow-up support supervision visit. The control group continued
usual symptom-based care according to existing Uganda Ministry of Health guidelines
RDT performed by treating clinician (usually clinical officer or nursing staff )
No other formal supervision was provided.
Outcomes Primary: patients with fever on day 4
Secondary:
1. patients still experiencing other symptoms on day 4;
2. patients given antimalarials
3. patients given antibiotics
Notes Country: Uganda
RDT: paracheck (HRP2)
Setting: peripheral health centres
Sampling: Lack of microscopy services, at least three full-time clinical staff, estimated
patient volume of at least 200 patients per week, willingness of health centre staff to
participate in the trial, and location within 20 km of a sentinel health centre established
by the Uganda Malaria Surveillance Project
Transmission: Very high; reference slide positivity in all participants with fever 73%
Dates: 2008; first half
Funding: Exxon Mobil Corp. via the Academic Alliance Foundation; and NIH, USA,
K23 AI065457-01
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Coin flip in the presence of health centre
leaders.
Allocation concealment (selection bias) Unclear risk Allocation of RDTs was decided by coin
flip in the presence of study staff and repre-
sentatives from eachmatched pair of health
centers
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Both the trial participants and personnel
were aware of intervention allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Both the trial participants and personnel
were aware of the diagnosis made and treat-
ment prescribed
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Hopkins 2008 UGA (V High) (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up was low (0.0% for pre-
scribing of antimalarials; 8.6% for clinical
outcomes, differentiated by trial group)
Performed available case analysis.
Selective reporting (reporting bias) Low risk Reported on all trial outcomes described in
the methodology.
Other bias Low risk No other sources of bias identified.
Skarbinski 2009 KEN
Methods Cluster RCT; randomized by health facilities
Stratified random selection of facilities, by transmission settings (high/low) and facility
type (hospitals, health centres and dispensaries)
Took into account a design effect of two in sampling
Reference slide taken. Results not reported
Trial lasted four months
Participants Inclusion: age ≥ 5 years, irrespective of condition
Number of participants randomized: Intervention arm: 799
Number analysed for primary outcome (prescribing of antimalarials): 669 (16.3% loss)
Interventions Intervention: RDTs for fever patients ≥ 5 years
Control: Presumptive treatment of fever
Boh groups received training and held guidelines
RDT performed by health workers
Health workers complied with guidelines partially: 41% of participants with negative
RDT results received antimalarials
Outcomes Primary outcomes:
1. Fever patients prescribed ACT
2. Microscopy negative patients prescribed ACT
Secondary outcomes:
1. RDT negative patients prescribed ACT; and RDT positive patients prescribed
ACT
2. Patients prescribed ACT presumptively
3. Patients with known alternative diagnosis receiving ACT
Notes Country: Kenya
RDT: paracheck
Setting: all referral levels of facilities, 60 in total, 30 in each arm
Transmission:Hyperendemic or holoendemic at some sites and low and seasonal at others
Dates: June to September 2006
Funding: USAID
Risk of bias
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Skarbinski 2009 KEN (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Systematic allocation.
Allocation concealment (selection bias) Unclear risk Although probabilistic sampling was used
in selecting the participating health facili-
ties, the participants had foreknowledge of
intervention assignments
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Both the trial participants and personnel
were aware of intervention allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Both the trial participants and personnel
were aware of the diagnoses and prescrip-
tions
Incomplete outcome data (attrition bias)
All outcomes
High risk Per protocol analysis; loss to follow-up was
high,more at the intervention facilities (20.
2%) than at the control facilities (11.2%)
Selective reporting (reporting bias) Low risk Reported on all pre-specified outcomes
(prescribing of ACT); did not explicitly re-
port onoverall antimalarial prescribing, but
the summary data were available for inclu-
sion in the review
Other bias Low risk Baseline imbalance minimised by stratify-
ing facilities by level and randomly select-
ing within each level
Summary data were adjusted for baseline
imbalance.
Results could be biased towards the null,
because some facilities in the comparison
arms had RDT
Loss of complete clusters: not reported.
Yeboah-Antwi 2010 ZAM
Methods Cluster randomized, by health posts. Pairs matched by distance from health centre then
randomized
Patinets follow-up and clinical status evaluated 5 to 7 days after initial contact
Estimates of measures of effects were adjusted for clustering & baseline imbalance using
generalised estimating equations with exchangeable correlation matrix
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Yeboah-Antwi 2010 ZAM (Continued)
Participants Inclusion: Children (6 months to 5 years); presenting with fever with or without other
conditions
Total enrolled and randomized: 3125 (1017 in the RDT arm and 2108 in the clinical
diagnosis arm)
Number analysed for primary outcomes: (a) prescribing of antimalarials: 3047 (2.5%
loss); (b) clinical outcomes: 3125 (0% loss)
Interventions Intervention: RDT-aided algorithm
Control: Clinical algorithm
Both groups received training and held guidelines
RDT performed by health workers; additional interventions provided to increase adher-
ence with RDT results
Health workers complied with guidelines most of the time: only 0.4% of participants
with negative RDT results received antimalarials
Outcomes 1. Children with fever who received AL
2. Children still experiencing symptoms at follow-up (day 5 to 7)
Notes Country: Zambia
RDT: ICT Malaria Pf (ICT Diagnostics)
Setting: Community health posts, manned by community health workers with six-week
training in basic clinical skills, rural and urban
Sampling: 42 community health posts
Transmission: High prevalence (valley) and low prevalence (plateau) areas
Dates: Between December 2007 and November 2008
Funding: Not provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Authors report random allocation; num-
bers were generated by random number
generator
Allocation concealment (selection bias) Unclear risk Participants were aware beforehand of the
diagnostic procedures theywere assigned to
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Both the trial participants and personnel
were aware of the diagnostic procedures ap-
plied
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Both the trial participants and personnel
were aware of the diagnostic outcomes, and
the medications prescribed
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Yeboah-Antwi 2010 ZAM (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up was low and comparable
in both settings (2.5% in patients assessed
for prescribing of antimalarials; 3% in pa-
tients assessed for clinical outcomes)
Selective reporting (reporting bias) Low risk Reported on all pre-specified outcomes.
Other bias Low risk Recruitment bias was low-pairs of aid posts
werematched by distance then randomized
Baseline imbalance: selected clusters were
similar and imbalance adjusted for
Loss of whole clusters: no loss reported.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Chinkhumba 2010 Not a RCT but a cross-sectional survey, without a comparison group
D’Acremont 2011 Intervention facilities were selected purposively; there was no random assignment to comparison arms
Faucher 2010 Not a RCT; and examined the effect of withholding anti-malaria to RDT-positive children rather than com-
paring RDT-based policy with presumptive treatment
Kyabayinze 2010 Not a RCT.
Msellem 2009 Not a RCT (weekly cross-over of intervention).
Mubi 2011 Not a RCT(weekly cross-over of intervention).
Reyburn 2007 Comparison was policy based on microscopy rather than presumptive treatment
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D A T A A N D A N A L Y S E S
Comparison 1. RDT-supported diagnosis versus Clinical diagnosis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patients still unwell at follow-up
at day 4+
5 6990 Risk Ratio (Random, 95% CI) 0.90 [0.69, 1.17]
2 Patients still unwell at follow-up
at day 4+; subgrouped by
health worker adherence to the
RDT result
5 6990 Risk Ratio (Random, 95% CI) 0.90 [0.69, 1.17]
2.1 Very low health worker
adherence
1 2095 Risk Ratio (Random, 95% CI) 1.01 [0.73, 1.41]
2.2 High health worker
adherence
4 4895 Risk Ratio (Random, 95% CI) 0.74 [0.48, 1.14]
3 Patients with fever prescribed
antimalarials
7 17287 Risk Ratio (Random, 95% CI) 0.62 [0.52, 0.73]
4 Patients with fever prescribed
antimalarials; subgrouped by
health worker adherence to the
RDT result
7 Risk Ratio (Random, 95% CI) Subtotals only
4.1 High health worker
adherence
4 11007 Risk Ratio (Random, 95% CI) 0.44 [0.29, 0.67]
4.2 Low health worker
adherence
1 3442 Risk Ratio (Random, 95% CI) 0.76 [0.74, 0.79]
4.3 Very low health worker
adherence
2 2838 Risk Ratio (Random, 95% CI) 0.90 [0.68, 1.20]
5 Patients with fever prescribed
antimalarials; trials with high
health worker adherence
subgrouped by malaria
prevalence (RDT positivity)
4 Risk Ratio (Random, 95% CI) Subtotals only
5.1 Very high endemicity (>
70% of RDTs positive)
1 4197 Risk Ratio (Random, 95% CI) 0.75 [0.73, 0.77]
5.2 High endemicity (40% to
70% of RDTs positive)
1 2213 Risk Ratio (Random, 95% CI) 0.45 [0.40, 0.51]
5.3 Moderate endemicity (<
40% RDTs positive)
2 4597 Risk Ratio (Random, 95% CI) 0.32 [0.19, 0.53]
6 Patients with fever prescribed
antimalarials; subgrouped by
age
6 Risk Ratio (Random, 95% CI) Subtotals only
6.1 < 5yrs 5 7505 Risk Ratio (Random, 95% CI) 0.61 [0.27, 1.37]
6.2 ≥ 5 yrs 5 7613 Risk Ratio (Random, 95% CI) 0.51 [0.38, 0.67]
7 Patients with fever prescribed
antibiotics
5 13573 Risk Ratio (Random, 95% CI) 0.99 [0.85, 1.16]
8 Microscopy-positive patients not
prescribed antimalarials
1 1280 Risk Ratio (Fixed, 95% CI) 1.21 [0.64, 2.28]
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9 Microscopy-negative patients
prescribed antimalarials
1 2162 Risk Ratio (Random, 95% CI) 0.60 [0.57, 0.64]
Analysis 1.1. Comparison 1 RDT-supported diagnosis versus Clinical diagnosis, Outcome 1 Patients still
unwell at follow-up at day 4+.
Review: Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings
Comparison: 1 RDT-supported diagnosis versus Clinical diagnosis
Outcome: 1 Patients still unwell at follow-up at day 4+
Study or subgroup RDT diagnosis Clinical diagnosis log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Hopkins 2008 UGA (V High) (1) 571 388 -0.15376 (0.38581338) 12.1 % 0.86 [ 0.40, 1.83 ]
Hopkins 2008 UGA (High) (2) 216 267 -0.10648 (0.88651552) 2.3 % 0.90 [ 0.16, 5.11 ]
Hopkins 2008 UGA (Medium) (3) 141 187 -0.52858 (1.13977968) 1.4 % 0.59 [ 0.06, 5.50 ]
Yeboah-Antwi 2010 ZAM (4) 1017 2108 -0.38566 (0.2912085) 21.2 % 0.68 [ 0.38, 1.20 ]
Bisoffi 2009 BFA (5) 1024 0.00995033 (0.16889199) 1071 63.0 % 1.01 [ 0.73, 1.41 ]
Total (95% CI) 100.0 % 0.90 [ 0.69, 1.17 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.55, df = 4 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
Favours RDT Favours Clinical
(1) Hopkins 2010 UGA (V high): Patients or caregivers reporting no change or worsening symptoms at day 5
(2) Hopkins 2010 UGA (High): Patients or caregivers reporting no change or worsening symptoms at day 5
(3) Hopkins 2010 UGA (Medium): Patients or caregivers reporting no change or worsening symptoms at day 5
(4) Yeboah-Antwi 2010 ZAM: Patients with fever or fast/difficult breathing at day 5-7
(5) Bisoffi 2009 BFA: Patients with fever at day 4
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Analysis 1.2. Comparison 1 RDT-supported diagnosis versus Clinical diagnosis, Outcome 2 Patients still
unwell at follow-up at day 4+; subgrouped by health worker adherence to the RDT result.
Review: Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings
Comparison: 1 RDT-supported diagnosis versus Clinical diagnosis
Outcome: 2 Patients still unwell at follow-up at day 4+; subgrouped by health worker adherence to the RDT result
Study or subgroup RDT diagnosis Clinical diagnosis log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
1 Very low health worker adherence
Bisoffi 2009 BFA (1) 1024 0.00995033 (0.16889199) 1071 63.0 % 1.01 [ 0.73, 1.41 ]
Subtotal (95% CI) 63.0 % 1.01 [ 0.73, 1.41 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
2 High health worker adherence
Hopkins 2008 UGA (V High) (2) 571 388 -0.15376 (0.38581338) 12.1 % 0.86 [ 0.40, 1.83 ]
Hopkins 2008 UGA (High) (3) 216 267 -0.10648 (0.88651552) 2.3 % 0.90 [ 0.16, 5.11 ]
Hopkins 2008 UGA (Medium) (4) 141 187 -0.52858 (1.13977968) 1.4 % 0.59 [ 0.06, 5.50 ]
Yeboah-Antwi 2010 ZAM (5) 1017 2108 -0.38566 (0.2912085) 21.2 % 0.68 [ 0.38, 1.20 ]
Subtotal (95% CI) 37.0 % 0.74 [ 0.48, 1.14 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.32, df = 3 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 1.35 (P = 0.18)
Total (95% CI) 100.0 % 0.90 [ 0.69, 1.17 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.55, df = 4 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Chi2 = 1.23, df = 1 (P = 0.27), I2 =19%
0.05 0.2 1 5 20
Favours RDT Favours Clinical
(1) Bisoffi 2009 BFA: 55% of RDTs were positive but 89% of patients having an RDT received antimalarials
(2) Hopkins 2010 UGA (V High): 73% of RDTs were positive and 72% of patients having an RDT received antimalarials
(3) Hopkins 2010 UGA (High): 46% of RDTs were positive and 45% of patients having an RDT received antimalarials
(4) Hopkins 2010 UGA (Medium): 32% of RDTs were positive and 32% of patients having an RDT received antimalarials
(5) Yeboah-Antwi 2010 ZAM: 28% of RDTs were positive and 28% of patients having an RDT received antimalarials
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Analysis 1.3. Comparison 1 RDT-supported diagnosis versus Clinical diagnosis, Outcome 3 Patients with
fever prescribed antimalarials.
Review: Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings
Comparison: 1 RDT-supported diagnosis versus Clinical diagnosis
Outcome: 3 Patients with fever prescribed antimalarials
Study or subgroup RDT diagnosis Clinical diagnosis log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Hopkins 2008 UGA (V High) 2288 1909 -0.28979 (0.01360867) 17.0 % 0.75 [ 0.73, 0.77 ]
Hopkins 2008 UGA (High) 1073 1140 -0.79599 (0.06640322) 15.5 % 0.45 [ 0.40, 0.51 ]
Hopkins 2008 UGA (Medium) 602 948 -0.92901 (0.09979061) 13.9 % 0.39 [ 0.32, 0.48 ]
Bisoffi 2009 BFA 1058 0.01980263 (0.01742838) 1111 16.9 % 1.02 [ 0.99, 1.06 ]
Ansah 2010 GHA 1719 1723 -0.27444 (0.01690035) 16.9 % 0.76 [ 0.74, 0.79 ]
Skarbinski 2009 KEN 359 310 -0.27444 (0.11896469) 12.9 % 0.76 [ 0.60, 0.96 ]
Yeboah-Antwi 2010 ZAM 963 2084 -1.46968 (0.25472674) 6.9 % 0.23 [ 0.14, 0.38 ]
Total (95% CI) 100.0 % 0.62 [ 0.52, 0.73 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 375.99, df = 6 (P<0.00001); I2 =98%
Test for overall effect: Z = 5.57 (P < 0.00001)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Lower with RDT Lower with Clinical
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Analysis 1.4. Comparison 1 RDT-supported diagnosis versus Clinical diagnosis, Outcome 4 Patients with
fever prescribed antimalarials; subgrouped by health worker adherence to the RDT result.
Review: Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings
Comparison: 1 RDT-supported diagnosis versus Clinical diagnosis
Outcome: 4 Patients with fever prescribed antimalarials; subgrouped by health worker adherence to the RDT result
Study or subgroup RDT diagnosis Clinical diagnosis log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
1 High health worker adherence
Hopkins 2008 UGA (High) (1) 1073 1140 -0.79599 (0.06640322) 26.8 % 0.45 [ 0.40, 0.51 ]
Hopkins 2008 UGA (V High) (2) 2288 1909 -0.28979 (0.01360867) 27.4 % 0.75 [ 0.73, 0.77 ]
Hopkins 2008 UGA (Medium) (3) 602 948 -0.92901 (0.09979061) 25.9 % 0.39 [ 0.32, 0.48 ]
Yeboah-Antwi 2010 ZAM (4) 963 2084 -1.46968 (0.25472674) 19.9 % 0.23 [ 0.14, 0.38 ]
Subtotal (95% CI) 100.0 % 0.44 [ 0.29, 0.67 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 113.83, df = 3 (P<0.00001); I2 =97%
Test for overall effect: Z = 3.83 (P = 0.00013)
2 Low health worker adherence
Ansah 2010 GHA (5) 1719 1723 -0.27444 (0.01690035) 100.0 % 0.76 [ 0.74, 0.79 ]
Subtotal (95% CI) 100.0 % 0.76 [ 0.74, 0.79 ]
Heterogeneity: not applicable
Test for overall effect: Z = 16.24 (P < 0.00001)
3 Very low health worker adherence
Skarbinski 2009 KEN (6) 359 310 -0.27444 (0.11896469) 42.0 % 0.76 [ 0.60, 0.96 ]
Bisoffi 2009 BFA (7) 1058 0.01980263 (0.01742838) 1111 58.0 % 1.02 [ 0.99, 1.06 ]
Subtotal (95% CI) 100.0 % 0.90 [ 0.68, 1.20 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 5.99, df = 1 (P = 0.01); I2 =83%
Test for overall effect: Z = 0.71 (P = 0.47)
Test for subgroup differences: Chi2 = 7.90, df = 2 (P = 0.02), I2 =75%
0.2 0.5 1 2 5
Lower with RDT Lower with Clinical
(1) Hopkins 2010 UGA (High): 46% of RDTs were positive and 45% of patients having an RDT received antimalarials
(2) Hopkins 2010 UGA (V High): 73% of RDTs were positive and 72% of patients having an RDT received antimalarials
(3) Hopkins 2010 UGA (Medium): 32% of RDTs were positive and 32% of patients having an RDT received antimalarials
(4) Yeboah-Antwi 2010 ZAM: 28% of RDTs were positive and 28% of patients having an RDT received antimalarials
(5) Ansah 2010 GHA: 63% of RDTs were positive and 70% of patients having an RDT received antimalarials
(6) Skarbinski 2009 KEN: 4% of reference slides were positive and 41% of patients having an RDT received antimalarials
(7) Bisoffi 2009 BFA: 55% of RDTs were positive but 89% of patients having an RDT received antimalarials
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Analysis 1.5. Comparison 1 RDT-supported diagnosis versus Clinical diagnosis, Outcome 5 Patients with
fever prescribed antimalarials; trials with high health worker adherence subgrouped by malaria prevalence
(RDT positivity).
Review: Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings
Comparison: 1 RDT-supported diagnosis versus Clinical diagnosis
Outcome: 5 Patients with fever prescribed antimalarials; trials with high health worker adherence subgrouped by malaria prevalence (RDT positivity)
Study or subgroup RDT diagnosis Clinical diagnosis log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
1 Very high endemicity (> 70% of RDTs positive)
Hopkins 2008 UGA (V High) (1) 2288 1909 -0.28979 (0.01360867) 100.0 % 0.75 [ 0.73, 0.77 ]
Subtotal (95% CI) 100.0 % 0.75 [ 0.73, 0.77 ]
Heterogeneity: not applicable
Test for overall effect: Z = 21.29 (P < 0.00001)
2 High endemicity (40% to 70% of RDTs positive)
Hopkins 2008 UGA (High) (2) 1073 1140 -0.79599 (0.06640322) 100.0 % 0.45 [ 0.40, 0.51 ]
Subtotal (95% CI) 100.0 % 0.45 [ 0.40, 0.51 ]
Heterogeneity: not applicable
Test for overall effect: Z = 11.99 (P < 0.00001)
3 Moderate endemicity (< 40% RDTs positive)
Yeboah-Antwi 2010 ZAM (3) 963 2084 -1.46968 (0.25472674) 40.6 % 0.23 [ 0.14, 0.38 ]
Hopkins 2008 UGA (Medium) (4) 602 948 -0.92901 (0.09979061) 59.4 % 0.39 [ 0.32, 0.48 ]
Subtotal (95% CI) 100.0 % 0.32 [ 0.19, 0.53 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 3.91, df = 1 (P = 0.05); I2 =74%
Test for overall effect: Z = 4.33 (P = 0.000015)
Test for subgroup differences: Chi2 = 65.71, df = 2 (P = 0.00), I2 =97%
0.2 0.5 1 2 5
Lower with RDT Lower with Clinical
(1) Hopkins 2010 UGA (V High): 73% of RDTs were positive and 72% of patients having an RDT received antimalarials
(2) Hopkins 2010 UGA (High): 46% of RDTs were positive and 45% of patients having an RDT received antimalarials
(3) Yeboah-Antwi 2010 ZAM: 28% of RDTs were positive and 28% of patients having an RDT received antimalarials
(4) Hopkins 2010 UGA (Medium): 32% of RDTs were positive and 32% of patients having an RDT received antimalarials
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Analysis 1.6. Comparison 1 RDT-supported diagnosis versus Clinical diagnosis, Outcome 6 Patients with
fever prescribed antimalarials; subgrouped by age.
Review: Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings
Comparison: 1 RDT-supported diagnosis versus Clinical diagnosis
Outcome: 6 Patients with fever prescribed antimalarials; subgrouped by age
Study or subgroup RDT diagnosis Clinical diagnosis log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
1 < 5yrs
Yeboah-Antwi 2010 ZAM 963 2084 -1.27297 (0.05487535) 28.0 % 0.28 [ 0.25, 0.31 ]
Hopkins 2008 UGA (Medium) 160 214 -0.52858 (1.13977968) 9.0 % 0.59 [ 0.06, 5.50 ]
Hopkins 2008 UGA (V High) 1360 934 -0.15376 (0.38581338) 22.6 % 0.86 [ 0.40, 1.83 ]
Ansah 2010 GHA 519 550 -0.15082 (0.02656639) 28.1 % 0.86 [ 0.82, 0.91 ]
Hopkins 2008 UGA (High) 367 354 -0.10648 (0.88651552) 12.3 % 0.90 [ 0.16, 5.11 ]
Subtotal (95% CI) 100.0 % 0.61 [ 0.27, 1.37 ]
Heterogeneity: Tau2 = 0.61; Chi2 = 339.17, df = 4 (P<0.00001); I2 =99%
Test for overall effect: Z = 1.20 (P = 0.23)
2≥ 5 yrs
Hopkins 2008 UGA (Medium) 442 734 -1.34707 (0.14843621) 17.6 % 0.26 [ 0.19, 0.35 ]
Hopkins 2008 UGA (High) 706 786 -0.94161 (0.10236723) 19.6 % 0.39 [ 0.32, 0.48 ]
Hopkins 2008 UGA (V High) 928 975 -0.59784 (0.06395955) 20.9 % 0.55 [ 0.49, 0.62 ]
Ansah 2010 GHA 1200 1173 -0.34249 (0.02157076) 21.7 % 0.71 [ 0.68, 0.74 ]
Skarbinski 2009 KEN 359 310 -0.27444 (0.08809864) 20.1 % 0.76 [ 0.64, 0.90 ]
Subtotal (95% CI) 100.0 % 0.51 [ 0.38, 0.67 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 87.40, df = 4 (P<0.00001); I2 =95%
Test for overall effect: Z = 4.75 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.17, df = 1 (P = 0.68), I2 =0.0%
0.05 0.2 1 5 20
Lower with RDT Lower with Clinical
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Analysis 1.7. Comparison 1 RDT-supported diagnosis versus Clinical diagnosis, Outcome 7 Patients with
fever prescribed antibiotics.
Review: Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings
Comparison: 1 RDT-supported diagnosis versus Clinical diagnosis
Outcome: 7 Patients with fever prescribed antibiotics
Study or subgroup RDT diagnosis Clinical diagnosis log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Hopkins 2008 UGA (V High) 2288 1909 -0.30925 (0.08824597) 18.8 % 0.73 [ 0.62, 0.87 ]
Hopkins 2008 UGA (High) 1075 1140 -0.04956 (0.0846485) 19.1 % 0.95 [ 0.81, 1.12 ]
Hopkins 2008 UGA (Medium) 602 948 0.185207 (0.10388352) 17.2 % 1.20 [ 0.98, 1.48 ]
Ansah 2010 GHA 1719 1723 0.173953 (0.0597961) 21.6 % 1.19 [ 1.06, 1.34 ]
Bisoffi 2009 BFA 1058 1111 -0.03046 (0.0397333) 23.3 % 0.97 [ 0.90, 1.05 ]
Total (95% CI) 100.0 % 0.99 [ 0.85, 1.16 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 24.85, df = 4 (P = 0.00005); I2 =84%
Test for overall effect: Z = 0.07 (P = 0.95)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Lower with RDT Lower with Clinical
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Analysis 1.8. Comparison 1 RDT-supported diagnosis versus Clinical diagnosis, Outcome 8 Microscopy-
positive patients not prescribed antimalarials.
Review: Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings
Comparison: 1 RDT-supported diagnosis versus Clinical diagnosis
Outcome: 8 Microscopy-positive patients not prescribed antimalarials
Study or subgroup RDT diagnosis Clinical diagnosis log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Ansah 2010 GHA (1) 647 633 0.19062 (0.32297626) 100.0 % 1.21 [ 0.64, 2.28 ]
Total (95% CI) 100.0 % 1.21 [ 0.64, 2.28 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.56)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Fewer with RDT Fewer with Clinical
(1) Ansah 2010 GHA: 41% of RDTs were positive and 70% of patients having an RDT received antimalarials
Analysis 1.9. Comparison 1 RDT-supported diagnosis versus Clinical diagnosis, Outcome 9 Microscopy-
negative patients prescribed antimalarials.
Review: Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings
Comparison: 1 RDT-supported diagnosis versus Clinical diagnosis
Outcome: 9 Microscopy-negative patients prescribed antimalarials
Study or subgroup RDT diagnosis Clinical diagnosis log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Ansah 2010 GHA (1) 1072 1090 -0.51083 (0.03004669) 100.0 % 0.60 [ 0.57, 0.64 ]
Total (95% CI) 100.0 % 0.60 [ 0.57, 0.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 17.00 (P < 0.00001)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Fewer with RDT Fewer with Clinical
(1) Ansah 2010 GHA: 41% of RDTs were positive and 70% of patients having an RDT received antimalarials
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A D D I T I O N A L T A B L E S
Table 1. Summary of characteristics of included studies
Characteris-
tic
Trial ID
Ansah 2010
GHA
Bisoffi 2009
BFA
Yeboah-
Antwi 2010
ZAM
Skarbinski
2009 KEN
Hopkins
2008UGA (V
High)
Hopkins
2008 UGA
(High)
Hopkins
2008 UGA
(Medium)
Setting
Country Ghana Burkina Faso Zambia Kenya Uganda Uganda Uganda
Endemicity Not indicated Seasonal High and low High and low Very high High Medium
Health facil-
ity, location
Health centres
or dispen-
saries; rural
Dispensaries,
rural & urban
Community
posts
Health centres
and hospitals
Health centres Health centres Health centres
Unit of ran-
domization
Individuals Individuals Clusters Clusters Clusters Clusters Clusters
Proportion of
RDTs positive
63% 53% 28% Not stated 73% 46% 32%
Proportion of
reference
slides positive
38% Not stated Not stated 4% 54% 37% 29%
Participants
Number
of health facil-
ities
3 10 31 30 2 2 2
Target
population for
malaria treat-
ment
All All < 5 years ≥ 5 years All All All
Number ran-
domized
3452 2169 3125 2004 4197 2213 1550
Number anal-
ysed for an-
timalarial pre-
scribing
3442 2169 3047 6691 4197 2213 1550
Loss to follow-
up
0.3% 0.0% 2.5% - 0.0% 0.0% 0.0%
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Table 1. Summary of characteristics of included studies (Continued)
Outcomes reported
Clincal
outcomes
No Yes Yes No Yes Yes Yes
Prescribing of
antimalarials
Yes Yes Yes Yes Yes Yes Yes
Prescribing of
antibiotics
Yes Yes No No Yes Yes Yes
1 Skarbinski 2009 KEN: 2004 participants were randomized but outcomes were collected through baseline and post intervention
surveys. 669 participants were evaluated in teh post-intervention survey.
Table 2. Description of the interventions
Characteris-
tic
Trial ID
Ansah 2010
GHA
Bisoffi 2009
BFA
Yeboah-
Antwi 2010
ZAM
Skarbinski
2009 KEN
Hopkins
2008UGA (V
High)
Hopkins
2008 UGA
(High)
Hopkins
2008 UGA
(Medium)
Training
Who was
trained to fol-
low the RDT
algorithm?
Nurses and
nursing assis-
tants
Nurses Community
healthworkers
Nurses, clini-
cal officers and
doctors
Clini-
cal officers and
nurses
Clini-
cal officers and
nurses
Clini-
cal officers and
nurses
Who
conducted the
training?
Nurses, after a
TOT course
Not described Experienced
IMCI trainers
Clini-
cal officers and
nurses, after a
two- week
TOT course
Experienced
national train-
ers
Experienced
national train-
ers
Experienced
national train-
ers
How long was
the training?
(days)
2 3 5 Half-day 3 3 3
Was a written
guideline pro-
vided?
Unclear Unclear Unclear Yes Yes Yes Yes
What supervi-
sion was con-
ducted?
Unclear Unclear Review
of records and
feedback each
month
Observation
and feedback
once after two
months
One day of
supportive su-
pervision two
weeks after the
One day of
supportive su-
pervision two
weeks after the
One day of
supportive su-
pervision two
weeks after the
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Table 2. Description of the interventions (Continued)
training training training
Were staff in-
centives pro-
vided?
No No Bicycles No No No No
Who
conducted the
RDT tests?
Research staff Research staff Prescribers Prescribers Prescribers Prescribers Prescribers
Which RDT-
type
OptiMAL-IT
(pLDH)
Paracheck
(HRP-2)
ICT malaria
Pf (HRP-2)
Paracheck
(HRP-2)
Paracheck
(HRP-2)
Paracheck
(HRP-2)
Paracheck
(HRP-2)
Were
the RDTs pro-
vided free?
Yes Yes Yes Yes Yes Yes Yes
Were the anti-
malarials pro-
vided free?
Yes Yes Yes Yes Yes Yes Yes
Were the an-
tibiotics pro-
vided free?
Yes Yes Yes Yes Yes Yes Yes
Algorithm
Test all cases
of fever with
RDTs
Yes Yes Yes Yes Yes Yes Yes
Prescribe only
if RDT is pos-
itive
Yes Yes Yes Yes Yes Yes Yes
Do not pre-
scribe if RDT
is negative
Yes Yes Yes Yes Yes Yes Yes
Treatment of
RDT negative
cases
Not described Look for other
causes
and treat as per
STG
Amoxicillin if
signs of pneu-
monia; else re-
fer
Not described Look for other
causes
and treat as per
STG
Look for other
causes
and treat as per
STG
Look for other
causes
and treat as per
STG
Guideline
on prescribing
antibiotics
Not
mentioned
Not
mentioned
Not
mentioned
If pneumonia
is suspected
Not
mentioned
Not
mentioned
Not
mentioned
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Table 3. Assessment of endemicity and health worker adherence
Trial ID Age group Proportion of
RDTs positive
(%)
Proportion of
reference slide
positive (%)
Endemicity
classification1
Proportion of patients pre-
scribed antimalarials (%)
Health worker
adherence clas-
sification2
RDT arm Clinical arm
Hopkins
2008UGA (V
High)
All 73 54 Very high 72 95 High
Bisoffi 2009
BFA
All 55 - High 89 87 Very low
Hopkins
2008 UGA
(High)
All 46 37 High 45 98 High
Ansah 2010
GHA
All 41 38 High 70 93 Low
Hopkins
2008 UGA
(Medium)
All 32 29 Moderate 32 98 High
Yeboah-
Antwi 2010
ZAM
< 5 28 - Moderate 28 99 High
Skarbinski
2009 KEN
> 5 - 4 Low 41 54 Very low3
1 The endemicity classification is the Cochrane Review authors’ judgement based on the proportion of RDTs testing positive: Very
high = > 60%; High = 40% to 59%; Moderate = 6% to 39%.
2 The health worker adherence classification is the Cochrane Review authors’ judgement and is based on the difference between the
proportion of RDTs testing positive and the proportion of patients being prescribed antimalarials in the RDT arm: High = difference
< 10%; Moderate = difference 11% to 20%; Low = difference 21% to 30%; Very low = difference > 30%.
3 For Skarbinski 2009 KEN, the proportion of RDTs testing positive was unavailable.
Table 4. Negative and positive predictive values of RDTs in trials by Hopkins et al
Trial ID Pro-
portion of
refer-
ence slides
positive
Number of patients1 Sensitivity
6
(95% CI)
Specificity
7
(95% CI)
NPV8 PPV9
TP2 FP3 TN4 FN5
Hopkins
2008
UGA (V
55% 1165
(51.1%)
454
(19.9%)
633
(27.8%)
26
(1.1%)
97.8% 59.4% 96.2% 72.0%
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Table 4. Negative and positive predictive values of RDTs in trials by Hopkins et al (Continued)
High)
Hopkins
2008
UGA
(High)
37% 347
(33.7%)
100
(9.7%)
567
(55.0%)
17
(1.7%)
95.3% 85.0% 97.1% 77.6%
Hopkins
2008
UGA
(Medium)
29% 145
(24.6%)
45
(7.5%)
378
(63.2%)
30
(5.0%)
82.9% 89.4% 92.7% 76.3%
1 This data has been taken from the trial data of Hopkins 2008 UGA (V High), Hopkins 2008 UGA (High), & Hopkins 2008 UGA
(Medium), and converted into a percentage.
2 TP = True positive = RDT positive and microscopy positive
3 FP = False positive = RDT positive and microscopy negative
4 TN = True negative = RDT negative and microscopy negative
5 FN = False negative = RDT negative and microscopy positive
6 Sensitivity = The proportion of people with fever due to malaria correctly identified with a positive RDT result = TP/(TP+FN)
7 Specificity = The proportion of people with fever due to non-malaria illness correctly identified with a negative RDT result = TN/
(TN+FP)
8 NPV = Negative predictive value = The proportion of people with a negative RDT result who have a non-malaria cause of their fever
= TN/(TN+FN)
9 PPV = Positive predictive value = The proportion of people with a positive RDT result who have malaria as a cause of their fever =
TP/(TP+FP)
A P P E N D I C E S
Appendix 1. Detailed search terms for electronic databases
Search set Search terms
1 Malaria
2 Fever
3 Febrile illness
4 1 or 2 or 3
5 Rapid diagnostic test
6 RDT
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(Continued)
7 Presumptive treatment
8 Syndromic approach
9 Treatment practice
10 Management
11 Prescription behaviour
12 Definite diagnosis
13 5-12/or
14 randomized controlled trial
15 random allocation
16 double blind method
17 single blind method
18 randomly
19 Clinical trials
20 14-19/or
21 4 and 13 and 20*
* Search terms 14-19 will not be applied to CENTRAL
Appendix 2. Summary statistics for outcomes assessed
Trial RDT algorithm Clinical algorithm
Events (%) Total Events (%) Total
1.0 Patients
1.1
Patients prescribed antimalarials
Yeboah-Antwi 2010
ZAM*
27.5 963 99.1 2084
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(Continued)
Hopkins 2008 UGA
(Medium)
31.7 602 99.3 948
Hopkins 2008 UGA
(High)
43.9 1073 98.0 1140
Hopkins 2008 UGA (V
High)
70.8 2288 94.6 1909
Skarbinski 2009 KEN 40.9 359 54.2 310
Ansah 2010 GHA 70.0 1719 92.7 1723
Bisoffi 2009 BFA 89.3 1058 87.2 1111
1.2
Microscopy positive patients receiving antimalarials
Ansah 2010 GHA 96.8 647 97.3 633
1.2
Microscopy positive patients missing antimalarials
Ansah 2010 GHA 3.2 647 2.7 633
1.3
Microscopy negative patients receiving antimalarials
Ansah 2010 GHA 53.9 1072 90.1 1090
1.4
Number prescribed antibiotics
Bisoffi 2009 BFA 52.9 1058 54.8 1111
Hopkins 2008 UGA
(Medium)
52.0 602 47.8 948
Hopkins 2008 UGA
(High)
51.9 1073 57.1 1140
Hopkins 2008 UGA (V
High)
42.5 2288 58.9 1909
Ansah 2010 GHA 26.6 1719 22.3 1723
1.5
Patients still unwell at follow-up at day 4, or after
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(Continued)
Yeboah-Antwi 2010
ZAM
9.3 1017 10.0 2108
Hopkins 2008 UGA
(Medium)
2.8 141 4.8 187
Hopkins 2008 UGA
(High)
3.7 216 4.1 267
Hopkins 2008 UGA (V
High)
9.3 571 10.8 388
Bisoffi 2009 BFA 5.6 1024 5.5 1071
2.0 Subgroups
2.1
Fever patients receiving antimalarials
2.1.1
< 5 years
Yeboah-Antwi 2010
ZAM*
27.5 963 99.1 2084
Ansah 2010 GHA 80.0 519 92.5 550
Hopkins 2008 UGA
(Medium)
46.9 160 99.1 214
Hopkins 2008 UGA
(High)
55.3 367 98.3 354
Hopkins 2008 UGA (V
High)
83.3 1360 93.4 934
2.1.2
≥ 5 years
Ansah 2010 GHA 65.8 1200 92.8 1173
Skarbinski 2009 KEN 40.9 359 54.2 310
Hopkins 2008 UGA
(Medium)
26.2 442 99.3 734
Hopkins 2008 UGA
(High)
38.0 706 97.8 786
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(Continued)
Hopkins 2008 UGA (V
High)
52.4 928 95.8 975
*RRs calculated from these summary statistics may be different from those in the analysis. In the analysis, the review authors extracted
RRs which had been adjusted for clustering and baseline imbalance
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Regarding outcomes:
1. We paraphrased measure of clinical outcomes to “patients still unwell at day 4+ of follow-up” and considered it as a primary
outcome. In the protocol we considered “persistence of fever at day 4+, based on self-report--not confirmed by means of a
thermometer” as a secondary outcome.
2. We included “Parasitaemia on day 4+” as a primary outcome in the protocol. We deleted this in the review because the trials
included are pragmatic in nature and did not assess parasitaemia.
3. “Microscopy positive patients not receiving antimalarials” was included as a secondary outcome because it is an issue of concern
to decision-makers.
4. We included “Microscopy negative patients prescribed antimalarials” as a secondary outcome measure because it is a measure of
antimalarial wastage, which is one of the primary reasons for introducing RDT-based policies.
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